 Shares of Mirati Therapeutics, Inc. NASDAQ: MRTX are retreating sharply Monday following two executive departures. What Happened: Mirati, a clinical-stage targeted oncology company, said its Chief Operating Officer Daniel Faga and Chief Medical Officer Joseph Leveque have stepped down from their respective roles. 